Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Radiodermatitis 2Neoplasms 2Multiple Myeloma 2Adenomatous Polyposis Coli 2Stomach Neoplasms 1Smoldering Multiple Myeloma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain 1Mucositis 1Monoclonal Gammopathy of Undetermined Significance 1Leukemia, Lymphocytic, Chronic, B-Cell 1Gastritis, Atrophic 1Fatigue 1Communicable Diseases 1Breast Carcinoma In Situ 1Adenocarcinoma 1

Interventions

Standard of Care 2Curcumin 2eucerin 1dimethicone 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1Zinc Oxide 1Triamcinolone Acetonide 1Sodium Hypochlorite 1Radiotherapy, Conformal 1Practice Guidelines as Topic 1Petrolatum 1Gels 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Radiodermatitis × Curcumin × Clear all
NCT02556632 2017-11-06

Curcumin-II

University of Rochester

Phase 2 Completed
191 enrolled 23 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Pain, Radiodermatitis

NCT01246973 2016-03-07

Oral Curcumin for Radiation Dermatitis

University of Rochester

Phase 2/3 Completed
686 enrolled 8 charts

Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡